Palaniyandi, Senthilnathan
Strattan, Ethan
Kumari, Reena
Mysinger, Miranda
Hakim, Natalya
Kesler, Melissa V.
Apatira, Mutiah
Bittencourt, Fabiola
Wang, Longcheng
Jia, Zhaozhong
Gururaja, Tarikere L.
Hill, Ronald J.
Hildebrandt, Gerhard C. https://orcid.org/0000-0003-0478-3340
Article History
Received: 19 January 2023
Revised: 6 April 2023
Accepted: 24 April 2023
First Online: 9 May 2023
Competing interests
: GCH and SP have received preclinical research funding from Pharmacyclics, Jazz Pharmaceuticals, Acerta Pharma and Incyte. Other authors declare no conflict of interest. This manuscript has been approved by all authors.